{"title": null, "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2004-10-22", "cleaned_text": "NIH Funding Opportunities and Notices for The Week Ending 10-26-2018 Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 10-26-2018 Table of Contents (TOC) [All NIH Funding Opportunities and Notices](http://grants.nih.gov/funding/searchguide/nih-guide-to-grants-and-contracts.cfm?Activity_Code=&Expdate_On_After=&OrderOn=RelDate&OrderDirection=DESC&OpeningDate_On_After=&maxreldate=2016-01-13%2013:49:42.0&Parent_FOA=All&PrimaryICActive=Any&RelDate_On_After=&Status=1&SearchTerms=&PAsToo=1&RFAsToo=1&NoticesToo=0&TitleText=&AppPackage=Any&Activity_Code_Groups=&Include_Sponsoring=1&SearchTermOperator=Logical_OR) Notices [Reminder: NIH Natural Disaster Policy - Hurricane Michael](/grants/guide/notice-files/NOT-OD-19-018.html) (NOT-OD-19-018) National Institutes of Health [Publication of the Revised NIH Grants Policy Statement (Rev. October 2018) for FY 2019](/grants/guide/notice-files/NOT-OD-19-021.html) (NOT-OD-19-021) National Institutes of Health [Notice of Information: Re-Opening the Comment Period for an NIH Proposal to Amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to Streamline Oversight of Human Gene Transfer Protocols](/grants/guide/notice-files/NOT-OD-19-022.html) (NOT-OD-19-022) National Institutes of Health [Notice of Intent to Publish Parent Funding Opportunity Announcements for Basic Experimental Studies with Humans](/grants/guide/notice-files/NOT-OD-19-024.html) (NOT-OD-19-024) National Institutes of Health [Notice of Participation of the National Institute on Aging (NIA) in PAR-18-714, \"Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)\"](/grants/guide/notice-files/NOT-AG-18-036.html) (NOT-AG-18-036) National Institute on Aging [PRE-SOLICITATION NOTICE: SIMIAN VACCINE EVALUATION UNITS (SVEUs)](/grants/guide/notice-files/NOT-AI-19-007.html) (NOT-AI-19-007) National Institute of Allergy and Infectious Diseases [Notice of NCCIH Participation in PAR-18-714, \"Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)\"](/grants/guide/notice-files/NOT-AT-19-010.html) (NOT-AT-19-010) National Center for Complementary and Integrative Health [Presolicitation Notice: Request for Proposals (RFP) N01CN87006-18 \"PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention\"](/grants/guide/notice-files/NOT-CA-19-004.html) (NOT-CA-19-004) National Cancer Institute [Notice of Intent to Publish a Funding Opportunity Announcement for Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical [Notice Biospecimen Funding Opportunity (U01)](/grants/guide/notice-files/NOT-CA-19-006.html) Institute [Notice of NIDA's participation in PAR-18-836 \"Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)\"](/grants/guide/notice-files/NOT-DA-19-004.html) (NOT-DA-19-004) National Institute on Drug Abuse [Notice of NIDA's participation in PAR-18-835 \"Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)\"](/grants/guide/notice-files/NOT-DA-19-005.html) (NOT-DA-19-005) National Institute on Drug Abuse [Notice of NIDCD Participation in PAR-18-714-Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)](/grants/guide/notice-files/NOT-DC-19-001.html) (NOT-DC-19-001) National Institute on Deafness and Other Communication Disorders [Notice of Clarification of Award Budget for PAR-18-656 NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)](/grants/guide/notice-files/NOT-DE-18-023.html) (NOT-DE-18-023) National Institute of Dental and Craniofacial Research [NIDDK Targeted SBIR Funding Opportunity Announcements Modified to Allow SBIR Direct-to-Phase II Applications](/grants/guide/notice-files/NOT-DK-19-003.html) (NOT-DK-19-003) National Institute of Diabetes and Digestive and Kidney Diseases [Notice of Intent to Publish a Funding Opportunity Announcement for Development of Translational Devices to Treat Pain (U18 Clinical Trial Not Allowed)](/grants/guide/notice-files/NOT-EB-18-030.html) (NOT-EB-18-030) National Institute of Biomedical Imaging and Bioengineering National Center for Complementary and Integrative Health Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Neurological Disorders and Stroke [Notice Announcing NIEHS Use of RFA-ES-16-005 \"Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)\" for Hurricanes Florence and Michael Response Research](/grants/guide/notice-files/NOT-ES-19-001.html) (NOT-ES-19-001) National Institute of Environmental Health Sciences [Notice Announcing NIEHS Use PA-18-591 \"Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)\" for Hurricane Florence Research Response](/grants/guide/notice-files/NOT-ES-19-002.html) (NOT-ES-19-002) National Institute of Environmental Health Sciences [Notice Announcing NIEHS Use of PA-18-935 \"Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)\" for Hurricanes Florence and Michael Research Response](/grants/guide/notice-files/NOT-ES-19-003.html) (NOT-ES-19-003) National Institute of Environmental Health Sciences [Changes in NIGMS Support of Integrated Predoctoral Dual-degree M.D.-Ph.D. Training through the Medical Scientist Training Program](/grants/guide/notice-files/NOT-GM-18-047.html) (NOT-GM-18-047) National Institute of General Medical Sciences [Notice of NIGMS Participation in PA-19-029 Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)](/grants/guide/notice-files/NOT-GM-19-001.html) (NOT-GM-19-001) National Institute of General Medical Sciences [Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIGMS SBIR FOAs](/grants/guide/notice-files/NOT-GM-19-003.html) (NOT-GM-19-003) National Institute of General Medical Sciences [Notice to Clarify the Participation of Foreign Scientists in PAR-17-340 \"Collaborative Program Grant for Multidisciplinary Teams (RM1)\"](/grants/guide/notice-files/NOT-GM-19-004.html) (NOT-GM-19-004) National Institute of General Medical Sciences [NICHD Policy on Monitoring and Oversight of Clinical Trials](/grants/guide/notice-files/NOT-HD-18-020.html) (NOT-HD-18-020) Eunice Kennedy Shriver National Institute of Child Health and Human Development [Notice of Pre-Application Technical Assistance Webinar for RFA-HD-19-022, Reproductive Medicine Clinical Trials Program (Collaborative R01 Clinical Trial Required)](/grants/guide/notice-files/NOT-HD-18-022.html) (NOT-HD-18-022) Eunice Kennedy Shriver National Institute of Child Health and Human Development [Notice Inviting the Community to Contribute to the Generation of NHGRI's '2020 Vision for Genomics'](/grants/guide/notice-files/NOT-HG-19-005.html) (NOT-HG-19-005) National Human Genome Research Institute [Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NHGRI Associated SBIR FOAs](/grants/guide/notice-files/NOT-HG-19-006.html) (NOT-HG-19-006) National Human Genome Research Institute [Notice of Intent to Publish a Funding Opportunity Announcement for Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)](/grants/guide/notice-files/NOT-HG-19-007.html) (NOT-HG-19-007) National Human Genome Research Institute [Notice of Intent to Publish a Funding Opportunity Announcement for High Quality Human Reference Genomes (HQRG) (UM1 Clinical Trial Not Allowed)](/grants/guide/notice-files/NOT-HG-19-008.html) (NOT-HG-19-008) National Human Genome Research Institute [Notice of Intent to Publish a Funding Opportunity Announcement for Research and Development for Genome Reference Representations (GRR) (U01, Clinical Trial Not Allowed)](/grants/guide/notice-files/NOT-HG-19-009.html) (NOT-HG-19-009) National Human [Notice of NHLBI Participation in PA-19-029 \"Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed) issued by the National Institutes of Health.](/grants/guide/notice-files/NOT-HL-18-658.html) (NOT-HL-18-658) National Heart, Lung, and Blood Institute [Request for Information (RFI): Soliciting input for future research at the NHLBI regarding Late complications after allogeneic hematopoietic stem cell transplantation or autologous gene modified stem cell transplant for non-malignant blood disorders](/grants/guide/notice-files/NOT-HL-18-659.html) (NOT-HL-18-659) National Heart, Lung, and Blood Institute [Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders](/grants/guide/notice-files/NOT-HL-18-660.html) (NOT-HL-18-660) National Heart, Lung, and Blood Institute [Notice of Change to Funding Opportunity Announcement, RFA-MD-18-012 Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional)\" Regarding Late Applications](/grants/guide/notice-files/NOT-MD-18-019.html) (NOT-MD-18-019) National Institute on Minority Health and Health Disparities [Notice of Information: NIMHs Interest in Areas of Stress Biology Research](/grants/guide/notice-files/NOT-MH-18-058.html) (NOT-MH-18-058) National Institute of Mental Health [Notice to Extend PAR-18-941 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)](/grants/guide/notice-files/NOT-MH-18-060.html) (NOT-MH-18-060) National Institute of Mental Health [Notice to Extend PAR-18-942 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)](/grants/guide/notice-files/NOT-MH-18-061.html) (NOT-MH-18-061) National Institute of Mental Health [Request for Information (RFI): Guidance on Current Clinical Experience with the Use of Ketamine for Suicide Prevention](/grants/guide/notice-files/NOT-MH-18-068.html) (NOT-MH-18-068) National Institute of Mental Health [Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)](/grants/guide/notice-files/NOT-NS-19-009.html) (NOT-NS-19-009) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health Eunice Kennedy Shriver National Institute of Child Health and Human Development [Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (U44 Clinical Trial Optional)](/grants/guide/notice-files/NOT-NS-19-010.html) (NOT-NS-19-010) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health Eunice Kennedy Shriver National Institute of Child Health and Human Development [Notice of Change to Application Due Date for Administrative Supplement for the NINDS Research Education Program for Residents and Fellow in Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supplement)](/grants/guide/notice-files/NOT-NS-19-013.html) (NOT-NS-19-013) National Institute of Neurological Disorders and Stroke [Notice of Correction to Revise Application Due Dates for PAR-18-910 Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)](/grants/guide/notice-files/NOT-TR-19-008.html) (NOT-TR-19-008) National Center for Advancing Translational Sciences [Notice of Correction to Revise Application Due Dates for NOT-TR-19-001 Notice of Availability of Administrative Supplements for Microphysiological Systems Developers: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose](/grants/guide/notice-files/NOT-TR-19-009.html) (NOT-TR-19-009) National Center for Advancing Translational Sciences [Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program](/grants/guide/notice-files/NOT-TW-18-005.html) (NOT-TW-18-005) John E. Fogarty International Center National Institute of Allergy and Infectious Diseases National Institute of General Medical Sciences [Notice of Change in Application Due Date for PAR-17-001 \"Emerging Global Leader Award (K43)\"](/grants/guide/notice-files/NOT-TW-18-006.html) (NOT-TW-18-006) John E. Fogarty International Center Requests for Applications [Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)](/grants/guide/rfa-files/RFA-AG-19-025.html) (RFA-AG-19-025) National Institute on Aging Application Receipt Date(s): March 8, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed)](/grants/guide/rfa-files/RFA-AG-19-026.html) (RFA-AG-19-026) National Institute on Aging Application Receipt Date(s): March 8, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [A Census of Cells and Circuits in the Aging Brain (R01 Clinical Trial Not Allowed)](/grants/guide/rfa-files/RFA-AG-19-027.html) (RFA-AG-19-027) National Institute on Aging Application Receipt Date(s): March 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)](/grants/guide/rfa-files/RFA-FD-20-001.html) (RFA-FD-20-001) Food and Drug Administration Application Receipt Date(s): June 25, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. [Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required)](/grants/guide/rfa-files/RFA-HD-19-022.html) (RFA-HD-19-022) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): January 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Early Screening for Autism Spectrum Disorder (R01 Clinical Trial Not Allowed)](/grants/guide/rfa-files/RFA-MH-19-120.html) (RFA-MH-19-120) National Institute of Mental Health National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of Neurological Disorders and Stroke Application Receipt Date(s): February 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. [Early Screening for Autism Spectrum Disorder (R21 Clinical Trial Not Allowed)](/grants/guide/rfa-files/RFA-MH-19-121.html) (RFA-MH-19-121) National Institute of Mental Health Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of Neurological Disorders and Stroke Application Receipt Date(s): February 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement?. [NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50 Clinical Trial Optional)](/grants/guide/rfa-files/RFA-NS-18-026.html) (RFA-NS-18-026) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): January 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinical Trial Optional)](/grants/guide/rfa-files/RFA-NS-18-027.html) (RFA-NS-18-027) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): January 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)](/grants/guide/rfa-files/RFA-NS-19-006.html) (RFA-NS-19-006) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Application Receipt Date(s): January 4, 2019, June 27 2019, February 27, 2020, November 27, 2020, June 27, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Program Announcements [Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)](/grants/guide/pa-files/PA-19-033.html) (PA-19-033) National Institute of Dental and Craniofacial Research National Center for Advancing Translational Sciences National Cancer Institute National Heart, Lung, and Blood Institute National Institute of Mental Health National Library of Medicine Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. [Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)](/grants/guide/pa-files/PA-19-034.html) (PA-19-034) National Institute of Dental and Craniofacial Research National Center for Advancing Translational Sciences National Cancer Institute National Heart, Lung, and Blood Institute National Institute of Mental Health National Library of Medicine Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. [Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed)](/grants/guide/pa-files/PA-19-035.html) (PA-19-035) National Cancer Institute Application Receipt Date(s): December 15, 2018, by 10:00 AM EDT. Late applications will not be accepted. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)](/grants/guide/pa-files/PAR-19-032.html) (PAR-19-032) National Library of Medicine Application Receipt Date(s): February 26, 2019 and February 26, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. [Medical Scientist Training Program (T32)](/grants/guide/pa-files/PAR-19-036.html) (PAR-19-036) National Institute of General Medical Sciences Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first application due date for this FOA is May 25, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Initiative for Maximizing Student Development (IMSD) (T32)](/grants/guide/pa-files/PAR-19-037.html) (PAR-19-037) National Institute of General Medical Sciences Application Receipt Date(s): February 22, 2019; January 28, 2020; January 28, 2021, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Emerging Global Leader Award (K43 Independent Clinical Trial Required)](/grants/guide/pa-files/PAR-19-038.html) (PAR-19-038) John E. Fogarty International Center National Cancer Institute National Human Genome Research Institute National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Office of Research on Women's Health Application Receipt Date(s): November 28, 2018; November 7, 2019; and November 4, 2020 by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. [Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)](/grants/guide/pa-files/PAR-19-039.html) (PAR-19-039) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Environmental Health Sciences Application Receipt Date(s): September 10, 2019; October 8, 2020; September 14, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)](/grants/guide/pa-files/PAR-19-040.html) (PAR-19-040) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Environmental Health Sciences Application Receipt Date(s): September 10, 2019; October 8, 2020, September 14, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. [Past Tables of Contents](/grants/guide/YearlyIndex/AllYearsIndex.cfm) | | | Department of Health | and Human Services | || | | National Institutes of Health (NIH) | 9000 Rockville Pike "}